2020 news
-
White Rose Biomaterials and Tissue Engineering Group (BiTEG) annual meeting – Thursday 17 December 2020
The Biomaterials and Tissue Engineering Group (BiTEG) 22nd annual meeting was hosted by the University of Leeds as an online event on Thursday 17 December 2020.
-
Possible broad spectrum drug treatment for viruses on the horizon
Researchers from the Universities of York and Melbourne have shed new light on how viruses like hepatitis B, dengue and SARS-CoV-2 hijack a cell paving the way for potential anti-viral drugs to stop the virus in its tracks.
-
CFH Early Career Fellow awarded Leukaemia Fellowship
The Department of Biology's Dr Katherine Bridge has just been awarded the Kay Kendall Leukaemia Fund Intermediate Fellowship for her research, one of only two recipients this year.
-
York scientist part of team awarded £8m to unravel breakdown of carbohydrates
A team of scientists - including an academic from the University of York - has been awarded more than £8m (9.1m euros) for a major research programme into how enzymes work on complex sugars.
-
Research fellowship to explore tuberculosis treatments
Pioneering research at the University of York could help us understand how the latest new antibiotics against tuberculosis (TB) work - and pave the way for improved treatments in the future.
-
Drug for common liver condition may be effective treatment for dementia and motorneuron disease, study suggests
A drug used to treat cirrhosis of the liver may be an effective treatment for a form of Dementia and motorneuron disease, scientists have discovered.
-
UK-Japan partnership to explore blood stem cell expansion
Researchers at York are to explore new advances in human blood stem cell research with partners in Japan and Cambridge.
-
Scientists join forces to address key unanswered questions about immunity and COVID-19
UK Scientists are launching a major new project to answer key questions on how the immune system interacts with COVID-19, in order to develop better treatments, diagnostics and vaccines.
-
Chemical offers new hope of finding treatments for neglected tropical diseases
Scientists say they are a step closer to developing a drug to kill the trypanosome parasite that causes human African trypanosomiasis, otherwise known as sleeping sickness, paving the way for a potential cure.
-
New sensor technology could speed up blood tests for COVID patients
Researchers are using laser-light technology to develop handheld biosensors with the potential to deliver fast, real-time blood test results for patients including those suffering from COVID-19 with secondary infections such as pneumonia.
-
New study discovers gene that keeps our immune system in check
Researchers at York have discovered a new mechanism which is used by cells of the immune system to control the strength of our response to infections.
-
New insights into COVID-19
Research from the Department of Chemistry in York is providing vital insights into the novel Coronavirus SARS-CoV-2, and may help underpin antibody tests and future therapies.
-
York scientists analyse COVID-19 protein in a bid to crack genetic safeguard
A team from the University of York have produced a protein which stores and protects the genome of the SARS-CoV-2 virus, which causes COVID-19, paving the way to possible antiviral therapies.
-
University of York loans bioscience equipment to York Hospital to help in diagnosis of Coronavirus cases
A piece of high-tech equipment used for the diagnosis of COVID-19 has been loaned to York Hospital by the University of York.
-
New interdisciplinary research to study protein scaffolds for biotechnology
Steve Johnson is co-investigator on a new BBSRC (Biotechnology and Biological Sciences Research Council) Tools and Technology grant.
-
Scientists discover how rogue communications between cells lead to Leukaemia
New research has deciphered how rogue communications in blood stem cells can cause Leukaemia.
-
21st annual BiTEG meeting report
York hosted the 21st annual 'Work in Progress Meeting' of the White Rose Biomaterials and Tissue Engineering Group on 16 December.